Cargando…
A Case Report of Hepatocellular Carcinoma in a Non-cirrhotic Patient With Liver Iron Overload Associated With Myelodysplastic Syndrome
Hereditary hemochromatosis (HH) is associated with an increased risk for hepatocellular carcinoma (HCC) occurring predominantly in patients with cirrhosis at the time of diagnosis. However, HCC in non-cirrhotic liver of patients with secondary hemochromatosis is rare. A 67-year-old man with a histor...
Autores principales: | Ikoma, Naruhiko, Shinozaki, Hiroharu, Kozuki, Akihito, Ibuki, Sho, Sugano, Kokichi, Mukai, Makio, Masuda, Yoshihiro, Kobayashi, Kenji, Ogata, Yoshiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elmer Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5649850/ https://www.ncbi.nlm.nih.gov/pubmed/29147365 http://dx.doi.org/10.4021/wjon611e |
Ejemplares similares
-
Iron Overload in Myelodysplastic Syndromes: Pathophysiology, Consequences, Diagnosis, and Treatment
por: Lyle, Lindsey, et al.
Publicado: (2018) -
Overview of guidelines on iron chelation therapy in patients with myelodysplastic syndromes and transfusional iron overload
por: Gattermann, Norbert
Publicado: (2008) -
The Clinical Significance of Iron Overload and Iron Metabolism in Myelodysplastic Syndrome and Acute Myeloid Leukemia
por: Weber, Sarah, et al.
Publicado: (2021) -
The role of magnetic resonance imaging in the evaluation of transfusional iron overload in myelodysplastic syndromes
por: Petrou, Emmanouil, et al.
Publicado: (2015) -
High expression of APAF-1 elevates erythroid apoptosis in iron overload myelodysplastic syndrome
por: Gu, Shucheng, et al.
Publicado: (2013)